KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Current Leases: 2012-2025

Historic Current Leases for Exact Sciences (EXAS) over the last 8 years, with Sep 2025 value amounting to $31.9 million.

  • Exact Sciences' Current Leases rose 17.28% to $31.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.9 million, marking a year-over-year increase of 17.28%. This contributed to the annual value of $27.4 million for FY2024, which is 6.79% down from last year.
  • Latest data reveals that Exact Sciences reported Current Leases of $31.9 million as of Q3 2025, which was up 1.79% from $31.3 million recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Current Leases ranged from a high of $31.9 million in Q3 2025 and a low of $15.3 million during Q1 2021.
  • Its 3-year average for Current Leases is $29.2 million, with a median of $29.8 million in 2025.
  • Per our database at Business Quant, Exact Sciences' Current Leases surged by 78.86% in 2021 and then dropped by 10.53% in 2024.
  • Quarterly analysis of 5 years shows Exact Sciences' Current Leases stood at $19.7 million in 2021, then skyrocketed by 44.09% to $28.4 million in 2022, then grew by 3.52% to $29.4 million in 2023, then declined by 6.79% to $27.4 million in 2024, then grew by 17.28% to $31.9 million in 2025.
  • Its last three reported values are $31.9 million in Q3 2025, $31.3 million for Q2 2025, and $29.8 million during Q1 2025.